资讯
Leerink Partners called the announcement a ‘positive’ given the delayed timeframe and the uncertainty that the administration ...
The FDA will allow a new dosing schedule for Eli Lilly’s Alzheimer’s drug Kisunla that could lessen a known side effect of ...
Actithera’s radiopharma assets irreversibly bind to their targets, allowing for longer retention of the drug inside tumors.
Analysts said the deal with Novo was likely giving Hims “‘credibility’ or increased consumer traffic,” adding that the ...
H2 2025 catalysts to watch, biopharma implications of President Trump’s tax law, KalVista’s new hereditary angioedema drug that Marty Makary reportedly tried to reject, another lawsuit aimed at Health ...
The industry sector focused on aging is only about 10 years old, but acting on what scientists already know, a new crop of ...
The deal marks an end for CAR T company Cargo Therapeutics, which has been slashing its workforce and cutting programs since ...
BrainStorm Cell Therapeutics issued a statement Tuesday supporting a Citizens’ Petition submitted to the FDA requesting the ...
After issues with a batch of Jasper Therapeutics' investigational antibody led to "lower" therapeutic effects in several ...
President Donald Trump’s One Big Beautiful Bill, signed into law last week, reintroduces broader exemptions for orphan drugs from the IRA’s drug price negotiation program—a move welcomed by the ...
A readout from the company’s SUMMIT trial put its small molecule bezuclastinib on a collision course with rival Blueprint’s ...
After a season of regulatory upheaval, obesity and rare genetic diseases will likely remain major themes for biopharma in ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果